Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Core Laboratories Sees Q4 GAAP EPS $0.18-$0.22 vs $0.19 Est; Sees Sales $132.000M-$136.000M vs $128.575M Est

Author: Benzinga Newsdesk | October 22, 2025 04:18pm

Posted In: CLB